Vascular Plug Embolization of a Superior Mesenteric Arteriovenous Fistula: Case Report and Literature Review of Endovascular Treatment.

Arteriovenous fistula Portal vein thrombosis Vascular plug

Journal

EJVES vascular forum
ISSN: 2666-688X
Titre abrégé: EJVES Vasc Forum
Pays: England
ID NLM: 101766732

Informations de publication

Date de publication:
2023
Historique:
received: 15 07 2022
revised: 04 07 2023
accepted: 01 08 2023
medline: 29 9 2023
pubmed: 29 9 2023
entrez: 29 9 2023
Statut: epublish

Résumé

Arteriovenous fistula (AVF) rarely occurs in the portal venous system. Aetiologies include iatrogenic, surgical, and penetrating trauma of the abdomen. Clinical manifestations of superior mesenteric portal arteriovenous fistula (SMPAVF) are right heart failure, mesenteric ischaemia, or signs of portal hypertension. The case of a 42 year old man with a history of Crohn's disease who had a delayed symptomatic mesenteric portal AVF, occurring 20 years after ileocecal resection, which was subsequently managed by endovascular approach is reported. The patient presented with post-prandial abdominal pain for almost one year, and dyspnoea New York Heart Association stage II. There were no signs of portal hypertension. Pre-operative contrast enhanced computed tomography showed a high flow SMPAVF, with a short and wide neck (9 mm × 16 mm) at the level of the last collateral of the superior mesenteric artery. It was associated with a large aneurysm of the mesenteric vein. Vascular plug embolisation (Amplatzer 18 × 18 mm, Abbott, Chicago, IL, USA) by femoral access allowed exclusion of the SMPAVF and preserved arterial flow in the distal collaterals. During follow up, the patient developed portal vein thrombosis and required therapeutic anticoagulation for six months. In most cases, endovascular approaches are preferred in the management of SMPAVF. Endovascular approaches are based on minimally invasive techniques including embolisation (coiling or plug) and covered stenting. Vascular plug embolisation of SMPAVF is feasible and seems to be an effective technique, with the advantage of saving collaterals. Therapeutic anticoagulation should be considered post-operatively in cases with venous dilatation and reduced flow linked to exclusion of the AVF.

Identifiants

pubmed: 37771647
doi: 10.1016/j.ejvsvf.2023.08.001
pii: S2666-688X(23)00071-0
pmc: PMC10522866
doi:

Types de publication

Case Reports

Langues

eng

Pagination

37-41

Informations de copyright

© 2023 Published by Elsevier Ltd on behalf of European Society for Vascular Surgery.

Déclaration de conflit d'intérêts

None.

Références

Gastroenterology. 1997 Oct;113(4):1390-401
pubmed: 9322535
J Vasc Surg. 2021 Mar;73(3):1087-1094.e8
pubmed: 33002586
Ann Vasc Surg. 2014 Feb;28(2):490.e9-12
pubmed: 24200133
Ann Vasc Surg. 2009 Jan-Feb;23(1):99-102
pubmed: 19135911
Gastroenterology. 2019 May;156(6):1582-1599.e1
pubmed: 30771355
Surg Today. 1993;23(1):73-7
pubmed: 8461609
EJVES Short Rep. 2018 Jun 05;39:58-60
pubmed: 29988873
Rev Esp Enferm Dig. 2016 Aug;108(8):503-7
pubmed: 26346106
Am J Transl Res. 2021 Jul 15;13(7):8172-8178
pubmed: 34377302
Balkan Med J. 2015 Apr;32(2):214-7
pubmed: 26167348

Auteurs

Tom Teniere (T)

Department of Vascular Surgery, Rouen University Hospital, Rouen, France.

Mickael Palmier (M)

Department of Vascular Surgery, Rouen University Hospital, Rouen, France.

Adelya Curado (A)

Department of Radiology, Rouen University Hospital, Rouen, France.

Didier Plissonnier (D)

Department of Vascular Surgery, Rouen University Hospital, Rouen, France.

Classifications MeSH